Publications by authors named "Sebastien Lafont"

The year 2022 saw record breaking temperatures in Europe during both summer and fall. Similar to the recent 2018 drought, close to 30% (3.0 million km) of the European continent was under severe summer drought.

View Article and Find Full Text PDF
Article Synopsis
  • Osteogenesis imperfecta (OI) is caused by collagen type 1 gene mutations, leading to low bone density and fragility, with reported gender differences in patients that lack consistent data.
  • A study previously showed that the sclerostin antibody (Scl-Ab) improved bone parameters in female oim/oim mice, and this research aimed to investigate its effects on male oim/oim mice.
  • Results indicated that while Scl-Ab enhanced bone density and structure in both male and female mice, male oim/oim had lower bone mineral content and more fractures than females, but Scl-Ab treatment helped improve their bone thickness and decrease fracture rates.
View Article and Find Full Text PDF

Drought and heat events, such as the 2018 European drought, interact with the exchange of energy between the land surface and the atmosphere, potentially affecting albedo, sensible and latent heat fluxes, as well as CO exchange. Each of these quantities may aggravate or mitigate the drought, heat, their side effects on productivity, water scarcity and global warming. We used measurements of 56 eddy covariance sites across Europe to examine the response of fluxes to extreme drought prevailing most of the year 2018 and how the response differed across various ecosystem types (forests, grasslands, croplands and peatlands).

View Article and Find Full Text PDF

In osteogenesis imperfecta (OI), vertebrae brittleness causes thorax deformations and leads to cardiopulmonary failure. As sclerostin-neutralizing antibodies increase bone mass and strength in animal models of osteoporosis, their administration in two murine models of severe OI enhanced the strength of vertebrae in growing female Crtap mice but not in growing male Col1a1 mice. However, these two studies ignored the impact of antibodies on spine growth, fracture rates, and compressive mechanical properties.

View Article and Find Full Text PDF
Article Synopsis
  • Osteogenesis imperfecta type III (OI) is a genetic disorder causing fragile bones and high fracture rates in children.
  • A monoclonal antibody that neutralizes sclerostin (Scl-Ab) has been shown to improve bone strength and reduce fractures in OI mice models.
  • After 9 weeks of treatment, Scl-Ab significantly decreased long bone fractures and increased key bone properties, suggesting it could be a promising treatment for minimizing long-bone fractures in OI patients.
View Article and Find Full Text PDF

For critical size bone defects and bone non-unions, bone tissue engineering using osteoblastic differentiated adipose mesenchymal stem cells (AMSCs) is limited by the need for a biomaterial to support cell transplantation. An osteoblastic three-dimensional autologous graft made of AMSCs (3D AMSC) was developed to solve this issue. This autograft was obtained by supplementing the osteoblastic differentiation medium with demineralized bone matrix.

View Article and Find Full Text PDF